Exposure to tetrabromobisphenol A induces cellular dysfunction in osteoblastic MC3T3-E1 cells

References

• Xu, W.; Wang, X.; Cai, Z. Analytical chemistry of the persistent organic pollutants identified in the Stockholm Convention: A review. Anal. Chim. Acta 2013, 790, 1–13.
   PubMed Web of Science ®Google Scholar
• Ogunbayo, O.A.; Jensen, K.T.; Michelangeli, F. The interaction of the brominated flame retardant: Tetrabromobisphenol A with phospholipid bilayers. Biochim. Biophys. Acta 2007, 1768, 1559–1566.
   PubMed Web of Science ®Google Scholar
• de Boer, J.; Wester, P.G.; Klamer, H.J.; Lewis, W.E.; Boon, J.P. Do flame retardants threaten ocean life? Nature 1998, 394, 28–29.
   PubMed Web of Science ®Google Scholar
• Jakobsson, K.; Thuresson, K.; Rylander, L.; Sjodin, A.; Hagmar, L.; Bergman, A. Exposure to polybrominated diphenyl ethers and tetrabromobisphenol A among computer technicians. Chemosphere 2002, 46, 709–716.
   PubMed Web of Science ®Google Scholar
• Cariou, R.; Antignac, J.P.; Zalko, D.; Berrebi, A.; Cravedi, J.P.; Maume, D.; Marchand, P.; Monteau, F.; Riu, A.; Andre, F.; Le Bizec, B. Exposure assessment of French women and their newborns to tetrabromobisphenol-A: Occurrence measurements in maternal adipose tissue, serum, breast milk and cord serum. Chemosphere 2008, 73, 1036–1041.
   PubMed Web of Science ®Google Scholar
• Schauer, U.M.; Vo¨lkel, W.; Dekant, W. Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration. Toxicol. Sci. 2006, 91, 49–58.
   PubMed Web of Science ®Google Scholar
• Fukuda, N.; Ito, Y.; Yamaguchi, M.; Mitumori, K.; Koizumi, M.; Hasegawa, R.; Kamata, E.; Ema, M. Unexpected nephrotoxicity induced by tetrabromobisphenol A in newborn rats. Toxicol. Lett. 2004, 150, 145–155.
   PubMed Web of Science ®Google Scholar
• Tada, Y.; Fujitani, T.; Yano, N.; Takahashi, H.; Yuzawa, K.; Ando, H.; Kubo, Y.; Nagasaw, A.; Ogata, A.; Kamimura, H. Effects of tetrabromobisphenol, brominated flame retardant, in ICR mice after prenatal and postnatal exposure. Food Chem. Toxicol. 2006, 44, 1408–1413.
   PubMed Web of Science ®Google Scholar
• Strack, S.; Detzel, T.; Wahl, M.; Kuch, B.; Krug, H.F. Cytotoxicity of TBBPA and effects on proliferation, cell cycle, MAPK pathways in mammalian cells. Chemosphere 2007, 67, 405–411.
   PubMed Web of Science ®Google Scholar
• Pullen, S.; Boecker, R.; Tiegs, G. The flame retardant tetrabromobisphenol A and tetrabromobispheol A-bisallyether suppress the induction of interleukin-2 receptor alpha chain (CD25) in murine splenocytes. Toxicology 2003, 184, 11–22.
   PubMed Web of Science ®Google Scholar
• Reistad, T.; Matiussen, E.; Fonnum, F. The effect of a brominated flame retardant, tetrabromobisphenol-A, on free radical formation in human neutrophil granulocytes: The involvement of the MAP kinase pathway and protein kinase C. Toxicol. Sci. 2005, 83, 89–100.
   Google Scholar
• Nakagawa, Y.; Suzuki, T.; Ishii, H.; Ogata, A. Biotransformation and cytotoxicity of a brominated flame retardant, tetrabromobisphenol A, and its analogues in rat hepatocytes. Xenobiotica 2007, 37, 693–708.
   PubMed Web of Science ®Google Scholar
• Reistad, T.; Mariussen, E.; Ring, A.; Fonnum, F. In vitro toxicity of tetrabromobisphenol-A on cerebellar granule cells: Free radical formation, calcium influx and extracellular glutamate. Toxicol. Sci. 2007, 96, 268–278.
   PubMed Web of Science ®Google Scholar
• Birnbaum, L.S.; Staskal, D.F. Brominated flame retardants: Cause for concern? Environ. Health Perspect. 2004, 112, 9–17.
   PubMed Web of Science ®Google Scholar
• Kitamura, S.; Suzuki, T.; Sanoh, S.; Kohta, R.; Jinno, N.; Sugihara, K.; Yoshihara, S.; Fujimoto, N.; Watanabe, H.; Ohta, S. Comparative study of the endocrine-disrupting activity of Bisphenol A and 19 related compounds. Toxicol. Sci. 2005, 84, 249–259.
   PubMed Web of Science ®Google Scholar
• Watt, J.; Schlezinger, J.J. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells. Toxicology 2015, 331, 66–77.
   PubMed Web of Science ®Google Scholar
• Hong, F.; Lee, J.; Song, J.W.; Lee, S.J.; Ahn, H.; Cho, J.J.; Ha, J.; Kim, S.S. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: Cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J. 2002, 16, 1633–1635.
   PubMed Web of Science ®Google Scholar
• Andreeva, L.; Heads, R.; Green, C.J. Cyclophilins and their possible role in the stress response. Int. J. Exp. Pathol. 1999, 80, 305–315.
   PubMed Web of Science ®Google Scholar
• Choi, K.J.; Piao, Y.J.; Lim, M.J.; Kim, J.H.; Ha, J.; Choe, W.; Kim, S.S. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Res. 2007, 67, 3654–3662.
   PubMed Web of Science ®Google Scholar
• van Dijk, F.S.; Nesbitt, I.M.; Zwikstra, E.H.; Nikkels, P.G.; Piersma, S.R.; Fratantoni, S.A.; Jimenez, C.R.; Huizer, M.; Morsman, A.C.; Cobben, J.M.; van Roij, M.H.; Elting, M.W.; Verbeke, J.I.; Wijnaendts, L.C.; Shaw, N.J.; Hogler, W.; McKeown, C.; Sistermans, E.A.; Dalton, A.; Meijers-Heijboer, H.; Pals, G. PPIB mutations cause severe osteogenesis imperfecta. Am. J. Hum. Genet. 2009, 85, 521–527.
   PubMed Web of Science ®Google Scholar
• Boyle, W.J.; Simonet, W.S.; Lacey, D.L. Osteoclast differentiation and activation. Nature 2003, 423, 337–342.
   PubMed Web of Science ®Google Scholar
• Parfitt, A.M. Bone remodeling and bone loss: Understanding the pathophysiology of osteoporosis. Clin. Obstetr. Gynecol. 1987, 30, 789–811.
   PubMed Web of Science ®Google Scholar
• Abbas, S.; Khan, K.; Khan, M.P.; Nagar, G.K.; Tewari, D.; Maurya, S.K.; Dubey, J.; Ansari, N.G.; Bandyopadhyay, S.; Chattopadhyay, N. Developmental exposure to As, Cd, and Pb mixture diminishes skeletal growth and causes osteopenia at maturity via osteoblast and chondrocyte malfunctioning in female rats. Toxicol. Sci. 2013, 134, 207–220.
   PubMed Web of Science ®Google Scholar
• Lind, P.M.; Eriksen, E.F.; Sahlin, L.; Edlund, M.; O¨rberg, J. Effects of the antiestrogenic environment pollutant 3,30,4,40,5-pentachlorobiphenyl (PCB#126) in rat bone and uterus: Diverging effects in ovariectomized and intact animals. Toxicol. Appl. Pharmacol. 1999, 154, 236–244.
   PubMed Web of Science ®Google Scholar
• Lind, P.M.; Larsson, S.; Oxlund, H.H.; Akansson, H.; Nyberg, K.; Eklund, T. Change of bone tissue composition and impaired bone strength in rats exposed to 3,30,4,40,5-penta chlorobiphenyl(PCB-126). Toxicology 2000, 150, 41–51.
   PubMed Web of Science ®Google Scholar
• Jamsa, T.; Viluksela, M.; Tuomisto, J.T.; Tuomisto, J.; Tuukanen, J. Effects of 2,3,7,8 tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures. J. Bone Miner. Res. 2001, 16, 1812–1820.
   PubMed Web of Science ®Google Scholar
• Cripps, D.; Peters, H.A.; Gocmen, A.; Dogramic, I. Porphyria turcica due to hexachlorobenzene: A 20 to 30 year follow-up study on 204 patients. Br. J. Dermatol. 1984, 111, 413–422.
   PubMed Web of Science ®Google Scholar
• Miller, R.W. Congenital PCB poisoning: A reevaluation. Environ. Health Perspect. 1985, 60, 211–214.
   PubMed Web of Science ®Google Scholar
• Komori, T. Regulation of osteoblast differentiation by transcription factors. J. Cell Biochem. 2006, 99, 1233–1239.
   PubMed Web of Science ®Google Scholar
• Genestra, M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 2007, 19, 1807–1819.
   PubMed Web of Science ®Google Scholar
• Lopez-Sanchez, N.; Rodriguez, J.R.; Frade, J.M. Mitochondrial c-Jun NH2-terminal kinase prevents the accumulation of reactive oxygen species and reduces necrotic damage in neural tumor cells that lack trophic support. Mol. Cancer Res. 2007, 5, 47–60.
   PubMed Web of Science ®Google Scholar
• Robinson, K.M.; Janes, M.S.; Beckman, J.S. The selective detection of mitochondrial superoxide by live cell imaging. Nat. Protoc. 2008, 3, 941–947.
   PubMed Web of Science ®Google Scholar
• Wang, P.; Heitman, J. The cyclophilins. Genome Biol. 2005, 6, 226.
   PubMed Web of Science ®Google Scholar
• Fischer, G.; Aumuller, T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 2003, 148, 105–150.
   PubMed Web of Science ®Google Scholar
• Galat, A. Peptidylprolyl cis/trans isomerases (immunophilins): Biological diversity–targets–functions. Curr. Top Med. Chem. 2003, 3, 1315–1347.
   PubMed Web of Science ®Google Scholar
• Jansen, G.; Maattanen, P.; Denisov, A.Y.; Scarffe, L.; Schade, B.; Balghi, H.; Dejgaard, K.; Chen, L.Y.; Muller, W.J.; Gehring, K.; Thomas, D.Y. An interaction map of endoplasmic reticulum chaperones and foldases. Mol. Cell Proteomics 2012, 11, 710–723.
   PubMed Web of Science ®Google Scholar
• Canesi, L.; Lorusso, L.C.; Ciacci, C.; Betti, M.; Gallo, G. Effects of the brominated flame retardant tetrabromobisphenol-A (TBBPA) on cell signaling and function of Mytilus hemocytes: Involvement of MAP kinases and protein kinase C. Aquat. Toxicol. 2005, 75, 277–287.
   PubMed Web of Science ®Google Scholar
• Ronisz, D.; Finne, E.F.; Karlsson, H.; Förlin, L. Effects of the brominated flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout. Aquat. Toxicol. 2004, 69, 229–245.
   PubMed Web of Science ®Google Scholar
• Hermes-Lima, M.; Willmore, W.G.; Storey, K.B. Quatification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation. Free Radic. Biol. Med. 1995, 19, 271–280.
   PubMed Web of Science ®Google Scholar
• Reistad, T.; Mariussen, E.; Fonnum, F. The effect of brominated flame retardants on cell death and free radical formation in cerebellar granule cells. Organohalogen Compd 2002, 57, 391–394.
   Google Scholar
• Howard, A.S.; Fitzpatrick, R.; Pessah, I.; Kostyniak, P.; Lein, P.J. Polychlorinated biphenyls induce caspase-dependent cell death in cultured embryonic rat hippocampal but not cortical neurons via activation of the ryanodine receptor. Toxicol. Appl. Pharmacol. 2003, 190, 72–86.
   PubMed Web of Science ®Google Scholar
• Ramadass, P.; Meerarani, P.; Toborek, M.; Robertson, L.W.; Hennig, B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhRDNA binding activity in vascular endothelial cells. Toxicol. Sci. Off. J. Soc. Toxicol. 2003, 76, 212–219.
   PubMed Web of Science ®Google Scholar
• Kumar, J.; Monica Lind, P.; Salihovic, S.; van Bavel, B.; Lind, L.; Ingelsson, E. Influence of persistent organic pollutants on oxidative stress in population-based samples. Chemosphere 2014, 114, 303–309.
   PubMed Web of Science ®Google Scholar
• Metodiewa, D.; Dunford, H.B. The role of myeloperoxidase in the oxidation of biologically active polyhydroxyphenols substituted catechols. Eur. J. Biochem. 1990, 193, 445–448.
   PubMedGoogle Scholar
• Whysner, J.; Wang, C.X. Hepatocellular iron accumulation and increased cell proliferation in polychlorinated biphenyl-exposed Sprague–Dawley rats and the development of hepatocarcinogenesis. Toxicol. Sci. 2001, 62, 36–45.
   PubMed Web of Science ®Google Scholar
• Bourgeon, S.; Leat, E.H.; Magnusdottir, E.; Fisk, A.T.; Furness, R.W.; Strøm, H.; Hanssen, S.A.; Petersen, A.; Olafsdottir, K.; Borga, K.; Gabrielsen, G.W.; Bustnes, J.O. Individual variation in biomarkers of health: Influence of persistent organic pollutants in Great skuas Stercorarius skua breeding at different geographical locations. Environ. Res. 2012, 118, 31–39.
   PubMed Web of Science ®Google Scholar
• Erikstad, K.E.; Sandvik, H.; Reiertsen, T.K.; Bustnes, J.O.; Strøm, H. Persistent organic pollution in a high-Arctic top predator: Sexdependent thresholds in adult survival. Proc. R. Soc. Lond. B 2013, 280, 20131483.
   PubMed Web of Science ®Google Scholar
• Grasselli, E.; Cortese, K.; Fabbri, R.; Smerilli, A.; Vergani, L.; Voci, A.; Gallo, G.; Canesi, L. Thyromimetic actions of tetrabromobisphenol A (TBBPA) in steatotic FaO rat hepatoma cells. Chemosphere 2014, 112, 511–518.
   PubMed Web of Science ®Google Scholar
• Gottlieb, R.A. Mitochondria: Execution central. FEBS Lett. 2000, 82, 6–12.
   Web of Science ®Google Scholar
• Petrosillo, G.; De Benedictis, V.; Ruggiero, F.M.; Paradies, G. Decline in cytochrome c oxidase activity in rat-brain mitochondria with aging. Role of peroxidized cardiolipin and beneficial effect of melatonin. J. Bioenerg. Biomembr. 2013, 45, 431–440.
   PubMed Web of Science ®Google Scholar
• Iverson, S.L.; Orrenius, S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch. Biochem. Biophys. 2004, 423, 37–46.
   PubMed Web of Science ®Google Scholar
• Chu, C.T.; Ji, J.; Dagda, R.K.; Jiang, J.F.; Tyurina, Y.Y.; Kapralov, A.A.; Tyurin, V.A.; Yanamala, N.; Shrivastava, I.H.; Mohammadyani, D. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 2013, 15, 1197–1205.
   PubMed Web of Science ®Google Scholar
• Bayir, H.; Tyurin, V.A.; Tyurina, Y.Y.; Viner, R.; Ritov, V.; Amoscato, A.A.; Zhao, Q.; Zhang, X.J.; Janesko-Feldman, K.L.; Alexander, H. Selective early cardiolipin peroxidation after traumatic brain injury: An oxidative lipidomics analysis. Ann. Neurol. 2007, 62, 154–169.
   PubMed Web of Science ®Google Scholar
• Kuwana, T.; Mackey, M.R.; Perkins, G.; Ellisman, M.H.; Latterich, M.; Schneiter, R.; Green, D.R.; Newmeyer, D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002, 111, 331–342.
   PubMed Web of Science ®Google Scholar
• Wei, M.C. Proapoptotic BAX and BAK: A requisite gateway to mitochondrialdysfunction and death. Science 2001, 292, 727–730.
   PubMed Web of Science ®Google Scholar
• Ryan, E.P.; Holz, J.D.; Mulcahey, M.; Sheu, T.J.; Gasiewicz, T.A.; Puzas, J.E. Environmental toxicants may modulate osteoblast differentiation by a mechanism involving the aryl hydrocarbon receptor. J. Bone Miner. Res. 2007, 22, 1571–1580.
   PubMed Web of Science ®Google Scholar
• Riu, A.; Grimaldi, M.; le Maire, A.; Bey, G.; Phillips, K.; Boulahtouf, A.; Perdu, E.; Zalko, D.; Bourguet, W.; Balaguer, P. Peroxisome proliferator-activated receptor c is a target for halogenated analogs of bisphenol A. Environ. Health Perspect. 2011, 119, 1227–1232.
   PubMed Web of Science ®Google Scholar
• Nishikawa, K.; Nakashima, T.; Takeda, S.; Isogai, M.; Hamada, M.; Kimura, A.; Kodama, T.; Yamaguchi, A.; Owen, M.J.; Takahashi, S.; Takayanagi, H. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 2010, 120, 3455–3465.
   PubMed Web of Science ®Google Scholar
• Jeon, M.J.; Kim, J.A.; Kwon, S.H.; Kim, S.W.; Park, K.S.; Park, S.W.; Kim, S.Y.; Shin, C.S. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J. Biol. Chem. 2003, 278, 23270–23277.
   PubMed Web of Science ®Google Scholar
• Moldes, M.; Zuo, Y.; Morrison, R.F.; Silva, D.; Park, B.H.; Liu, J.; Farmer, S.R. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem. J. 2003, 376, 607–613.
   PubMed Web of Science ®Google Scholar
• Kang, S.; Bennett, C.N.; Gerin, I.; Rapp, L.A.; Hankenson, K.D.; Macdougald, O.A. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2007, 282, 14515–14524.
   PubMed Web of Science ®Google Scholar
• Choi, S.S.; Kim, E.S.; Koh, M.; Lee, S.J.; Lim, D.; Yang, Y.R.; Jang, H.J.; Seo, K.A.; Min, S.H.; Lee, I.H.; Park, S.B.; Suh, P.G.; Choi, J.H. A novel non-agonist peroxisome proliferator-activated receptor gamma (PPARgamma) ligand UHC1 blocks PPARgamma phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity. J. Biol. Chem. 2014, 289, 26618–26629.
   PubMed Web of Science ®Google Scholar
• Lazarenko, O.P.; Rzonca, S.O.; Suva, L.J.; Lecka-Czernik, B. Netoglitazone is a PPAR-gamma ligands with selective effects on bone and fat. Bone 2006, 38, 74–84.
   PubMed Web of Science ®Google Scholar
• Kolli, V.; Stechschulte, L.A.; Dowling, A.R.; Rahman, S.; Czernik, P.J.; Lecka-Czernik, B. Partial agonist, telmisartan, maintains PPARg serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass. PLoS ONE 2014, 9, e96323.
   PubMed Web of Science ®Google Scholar
• Kim, H.; Oh, Y.; Kim, K.; Jeong, S.; Chon, S.; Kim, D.; Jung, M.H.; Pak, Y.K.; Ha, J.; Kang, I.; Choe, W. Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1. Biochem. Biophys. Res. Commun. 2015, 464, 112–117.
   PubMed Web of Science ®Google Scholar
• Yurchenko, V.; Constant, S.; Eisenmesser, E.; Bukrinsky, M. Cyclophilin-CD147 interactions: A new target for anti-inflammatory therapeutics. Clin. Exp. Immunol. 2010, 160, 305–317.
   PubMed Web of Science ®Google Scholar
• Kim, J.; Choi, T.G.; Ding, Y.; Kim, Y.; Ha, K.S.; Lee, K.H.; Kang, I.; Ha, J.; Kaufman, R.J.; Lee, J.; Choe, W.; Kim, S.S. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J. Cell Sci. 2008, 121, 3636–3648.
   PubMed Web of Science ®Google Scholar
• Jeong, K.; Kim, H.; Kim, K.; Kim, S.J.; Hahn, B.S.; Jahng, G.H.; Yoon, K.S.; Kim, S.S.; Ha, J.; Kang, I.; Choe, W. Cyclophilin B is involved in p300-mediated degradation of CHOP in tumor cell adaptation to hypoxia. Cell Death Differ. 2014, 21, 438–450.
   PubMed Web of Science ®Google Scholar
• Swanson, S.K.H.; Born, T.; Zydiwsky, L.D.; Cho, H.; Cang, H.Y.; Walsh, C.T.; Rusnak, F. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3741–3745.
   PubMed Web of Science ®Google Scholar
• Bukrinsky, M.I. Cyclophilins: Unexpected messengers in intercellular communications. Trends Immunol. 2002, 23, 323–325.
   PubMed Web of Science ®Google Scholar
• Watashi, K.; Ishii, N.; Hijikata, M.; Inoue, D.; Murata, T.; Miyanari, Y.; Shimotohno, K. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 2005, 19, 111–122.
   PubMed Web of Science ®Google Scholar
• Rycyzyn, M.A.; Reilly, S.C.; O'Malley, K.; Clevenger, C.V. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol. Endocrinol. 2000, 14, 1175–1186.
   PubMed Web of Science ®Google Scholar
• Marcant, A.; Denys, A.; Melchior, A.; Martinez, P.; Deligny, A.; Carpentier, M.; Allain, F. Cyclophilin B attenuates the expression of TNF-α in lipopolysaccharide-stimulated macrophages through the induction of B cell lymphoma-3. J. Immunol. 2012, 189, 2023–2032.
   PubMed Web of Science ®Google Scholar
• Smith, T.; Ferreira, L.R.; Hebert, C.; Norris, K.; Sauk, J.J. Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum. J. Biol. Chem. 1995, 270, 18323–18328.
   PubMed Web of Science ®Google Scholar
• Myllyharju, J.; Kivirikko, K.I. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004, 20, 33–43.
   PubMed Web of Science ®Google Scholar
• Cabral, W.A.; Perdivara, I.; Weis, M.; Terajima, M.; Blissett, A.R.; Chang, W.; Perosky, J.E.; Makareeva, E.N.; Mertz, E.L.; Leikin, S.; Tomer, K.B.; Kozloff, K.M.; Eyre, D.R.; Yamauchi, M.; Marini, J.C. Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta. PLoS Genet. 2014, 10, e1004465.
   PubMed Web of Science ®Google Scholar
• Young, J.C.; Agashe, V.R.; Siegers, K.; Hartl, F.U. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 2004, 5, 781–791.
   PubMed Web of Science ®Google Scholar
• Kettern, N.; Dreiseidler, M.; Tawo, R.; Hohfeld, J. Chaperone-assisted degradation: Multiple paths to destruction. Biol. Chem. 2010, 391, 481–489.
   PubMed Web of Science ®Google Scholar
• Iqbal, J.; Sun, L.; Cao, J.; Yuen, T.; Lu, P.; Bab, I.; Leu, N.A.; Srinivasan, S.; Wagage, S.; Hunter, C.A.; Nebert, D.W.; Zaidi, M.; Avadhani, N.G. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 11115–11120.
   PubMed Web of Science ®Google Scholar
• Korkalainen, M.; Kallio, E.; Olkku, A.; Nelo, K.; Ilvesaro, J.; Tuukkanen, J.; Mahonen, A.; Viluksela, M. Dioxins interfere with differentiation of osteoblasts and osteoclasts. Bone 2009, 44, 1134–1142.
   PubMed Web of Science ®Google Scholar
• Bock, K.W.; Kohle, C. Ah receptor: Dioxin-mediated toxicresponses as hints to deregulated physiologic functions. Biochem. Pharmacol. 2006, 72, 393–404.
   PubMed Web of Science ®Google Scholar
• Peters, A.K.; Van Londen, K.; Bergman, Å.; Bohonowych, J.; Denison, M.S.; Van den Berg, M.; Sanderson, J.T. Effects of polybrominated diphenyl ethers on basal and TCDD-induced ethoxyresorufin activity and cytochrome P450-1A1 expression in MCF-7, HepG2, and H4IIE cells. Toxicol. Sci. 2004, 82, 488–496.
   PubMed Web of Science ®Google Scholar
• Hu, F.; Pan, L.; Xiu, M.; Jin, Q.; Wang, G.; Wang, C. Bioaccumulation and detoxification responses in the scallop Chlamys farreri exposed to tetrabromobisphenol A (TBBPA). Environ. Toxicol. Pharmacol. 2015, 39, 997–1007.
   PubMed Web of Science ®Google Scholar